Business · 17/12/2021Updated: 10/17/2026 · 1 min read

FDA Announces Draft Guidance for Industry on Inspection of Injectable Products for Visible Particulates

The FDA is releasing a draft guidance to help industry develop and implement a holistic approach to controlling visible particulates in injectable products, which can pose patient safety risks.